Laser peripheral iridotomy and iridoplasty

Published on 08/03/2015 by admin

Filed under Opthalmology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3900 times

CHAPTER 44 Laser peripheral iridotomy and iridoplasty

Laser peripheral iridotomy

The continuous wave argon laser revolutionized the treatment of glaucoma. In 1973, Beckman and Sugar reported successful argon laser iridotomies in humans1. Others soon reported success in human eyes with angle closure2. The ease and convenience of the procedure for both patient and surgeon and the paucity of severe complications led to its rapid acceptance. ALPI was first described in 19823.

Indications

LPI is the procedure of choice for all forms of angle closure in which there is a component of pupillary block.

Surgical techniques

The various techniques for LPI as developed in the late 1970s and early 1980s, with multiple variations, are detailed elsewhere9. We describe our current most commonly used techniques and settings.

Contact lenses for laser procedures

Firm control of the contact lens reduces saccades and extraneous eye movements that interfere with accurate superimposition of burns. The lens helps to separate the lids, to focus the laser beam, and to minimize loss of laser power from reflection. By absorbing heat delivered through the cornea, the gonioscopy solution decreases the incidence of corneal burns.

The Abraham lens (Fig. 44.1) consists of a fundus lens with an anterior +66 diopter planoconvex button. The button magnifies without loss of depth of focus. The effective size of a 50 µm spot is reduced to approximately 30 µm; this provides higher energy per unit area and permits the procedure to require a lower total energy. Posterior to the site of focus, the beam is more rapidly defocused, decreasing potential injury to structures behind.

image

Fig. 44.1 Abraham laser contact lens – useful for both laser peripheral iridotomy and laser peripheral iridoplasty.

From Ritch R, Solomon IS. Glaucoma Surgery. In: L’Esperance FA, editor. Ophthalmic Lasers. 3rd ed. St. Louis: CV Mosby Co; 1988. p. 650-748.

Argon laser peripheral iridotomy

Contraction burn

This burn contracts the surrounding iris tissue towards, and compacts the stroma at the target site. Contraction burns are of low power, large spot size, and long duration. They (i) increase the density of iris stroma to facilitate laser energy absorption in blue or light brown irides, (ii) create a ‘hump’ on which penetrating burns are placed, and (iii) produce a peripheral iridoplasty or pupilloplasty effect. Settings are 500 µm spot size, 0.5–0.7 second duration, and 200–400 mW. If bubbles occur or pigment is released, reduce the power. Begin with 200 mW in brown irides and 300 mW in light ones, adjusting the power as necessary. In very light irides, a 200 µm spot size may be necessary.

There are two contraction burn techniques that we utilize: the linear incision and producing a contraction burn bed.

The linear incision technique involves placing a short line of circumferential burns instead of penetrating at a single spot (Fig. 44.2). When the stroma is fully incised in this manner, the iris dilator muscle assists in the separation of the iris pigment epithelium, reducing the amount of pigment epithelium which must be lasered and creating a larger opening.

image

Fig. 44.2 Laser application technique for peripheral iridotomy with linear incision placed within the area affected by one or more contraction burns.

From Ritch R, Solomon IS. Glaucoma Surgery. In: L’Esperance FA, editor. Ophthalmic Lasers. 3rd ed. St. Louis: CV Mosby Co; 1988. p. 650-748.

The contraction burn bed technique helps in lightly pigmented irides without crypts. One to three contraction burns are placed in a circumferential line, partially superimposed (see Fig. 44.2). Punch or penetrating burns are then placed using the contraction burns as a bed for the site of laser peripheral iridotomy. In very light irides, this method combined with linear incision usually results in larger iridotomies than attainable with other argon laser techniques. For light brown irides, we place a single contraction burn on either side of the selected penetration site (modified drumhead). The area between them is tautened and an iridotomy created with penetrating burns.

Penetrating burn

This is a higher power, small spot size burn designed to vaporize iris tissue and create an opening; use a 50 µm spot size. In the late 1970s and early 1980s, burns of 0.1 or 0.2 second duration were common. This introduces far too much power especially with dark brown irides. Shorter duration, lower power burns were shown to be more effective10, with less complications and less total energy for penetration. Burns of 0.01 or 0.02 second duration were formerly termed ‘punch burns’. The optimal power is between 600 and 1200 mW; it varies depending on burn duration and iris consistency and pigmentation.

Shorter duration (0.01 or 0.02 second) burns are optimal in dark irides, particularly in blacks and Asians, to avoid charring at the base of the iridotomy site. As they produce less thermal effect than longer duration burns, they are useful in all irides. Posterior synechiae may occur less frequently with short duration burns.

Our preferred approach is to perform linear incision using short duration penetrating burns for dark brown irides, a modified drumhead for medium brown irides, and penetration through contraction burns in combination with linear incision for light irides. Improvisation in technique and choice of laser settings for different types of irides is the key to success. The entire procedure may require anywhere from 1 to 300 burns.

For any iridotomy, the first burn often serves as an indicator for the ease of the procedure. The desired result is the appearance of a small hole with a dark brown base at the site of the burn and dispersion of debris into the anterior chamber. Bubble formation at the site of the burn indicates stromal vaporization. One then simply continues to deliver burns until the stroma has been penetrated.

In the absence of stromal pigmentation, bubble formation and pigment release may be minimal. One clue to the gradual deepening of the iridotomy is a gradual darkening of the base. An orange reflex at the time of beam impact, most commonly seen in irides with little stromal pigmentation, signifies that one is nearing the pigment epithelium.

When the iris pigment epithelium is reached, denser bursts of fine pigment (smoke signals) appear in the anterior chamber. A ‘mushroom cloud’ of pigment mixed with aqueous often slowly balloons into the anterior chamber. Simultaneously, the iris stroma floats backward and the peripheral anterior chamber deepens.

Cleanup burns

After penetration, the iridotomy may be enlarged and pigment epithelium removed with cleanup burns. Use either a low power penetrating burn (400–600 mW), or a longer, low power burn, such as 100 µm, 0.2 s duration, and 200 mW power. Occasionally, an impenetrable cord of stroma is present at the site of the iridotomy. One can create an opening on either side of this cord if it cannot be severed at its base.

At the completion of the iridotomy, the lens capsule should be visible through the opening (Fig. 44.3). If the opening is small and the capsule is not visible, one can often get a sense of depth behind the opening or note a green reflex off the lens capsule when the beam is applied to the opening. Gonioscopy should be performed to ensure that the angle is open.

image

Fig. 44.3 The lens capsule is visible through the iridotomy opening at the completion of laser peripheral iridotomy.

From Wise JB: Iris sphincterotomy, iridotomy, and synechiotomy by linear incision with the argon laser. Ophthalmology 1985;92:641.

Transillumination is not a reliable indicator of success in light irides. If too high a power is used in light irides, it is possible to destroy pigment epithelium without penetrating the stroma. Once this happens, the overlying stroma cannot be penetrated and the surgeon may be fooled into thinking the procedure has been successful.

Elevated IOP associated with LPI typically occurs in the first 1–2 hours postoperatively11. One should monitor IOP during this time. Postoperative topical steroids for several days are recommended to control inflammation.

Complications

Corneal damage

All corneal complications were more common with high power (1500–2000 mW), long duration (0.1–0.2 second) laser applications in dark brown irides. They rarely occur with the much shorter duration, lower power burns described above. These include epithelial and endothelial thermal burns, and corneal edema, abrasions, and opacities. Epithelial coagulation and whitening are transient, but may interfere with the delivery of laser energy and impede the creation of a patent iridotomy. If epithelial coagulation occurs, an attempt can be made to angle the beam around the burn to complete the iridotomy. If this is impossible, it may be necessary to choose another location for the iridotomy, use a Nd:YAG laser, or postpone completion of the iridotomy until the epithelium has healed. Stromal edema and striate keratopathy may also occur.

Endothelial burns from the argon laser are generally dense white with sharp margins and result from the thermal effects of iris photocoagulation. They require more time for resolution and may result in focal endothelial cell loss. Although endothelial cell loss following LPI has not been statistically significant during follow-up of up to 1 year, an increase in mean endothelial cell size and endothelial cell loss with greater laser power have been reported16. Both epithelial and endothelial burns have been rare since 0.1–0.2-second duration pulses have been abandoned.

Although endothelial cell analysis after Nd:YAG iridotomy may be unchanged17, focal endothelial cell loss has been documented when photodisruption is less than 1 mm from the corneal endothelium and at the site of treatment17. The area of focal loss is reduced in size with the use of an Abraham lens. Damage to Descemet’s membrane occurs when this distance is reduced to 0.1 mm. Progressive corneal edema requiring penetrating keratoplasty has been reported following Nd:YAG or argon LPI. Risk factors include pre-existing guttata and excessive laser energy.

Laser peripheral iridoplasty (ALPI)

Peripheral iridoplasty is a simple and effective means of opening an appositionally closed angle when LPI either cannot be performed or has not eliminated appositional angle closure because mechanisms other than pupillary block are present. Contraction burns (long duration, low power, and large spot size) are placed in the extreme iris periphery to contract the iris stroma and physically pull open the angle (Fig. 44.4)3.

Indications

Acute primary angle closure

ALPI can break an attack of acute primary angle closure which is unresponsive to medical therapy and where corneal edema, a shallow anterior chamber, or marked inflammation precludes immediate LPI. ALPI may also be useful for an attack which is unresponsive despite a patent iridotomy1,4. Circumferential treatment of the iris is virtually 100% successful at opening the angle in those areas in which there are no PAS. The effect lasts sufficiently long for the cornea and anterior chamber to clear so that iridotomy can be performed.

ALPI may be used as primary therapy in eyes with acute primary angle closure, either with or without preliminary treatment with topical medications2124. It was shown to be more effective than conventional systemic medications in lowering IOP in acute primary angle closure in a randomized controlled study23. Since ALPI does not eliminate pupillary block, LPI is still required in acute primary angle closure once IOP is controlled and the cornea has cleared sufficiently; otherwise the effect of ALPI may reverse.

Chronic angle closure

Eyes with chronic angle closure and a combination of PAS and appositional closure may respond to ALPI with opening of the appositionally closed portions of the angle, allowing filtration surgery to be avoided25. If extensive PAS are present after ALPI, goniosynechialysis (GSL) may be performed to surgically strip PAS from the angle wall to restore aqueous access to the trabecular meshwork.

Surgical techniques

References

1 Beckman H, Sugar HS. Laser iridectomy therapy of glaucoma. Arch Ophthalmol. 1973;90(6):453-455.

2 Abraham RK, Miller GL. Outpatient argon laser iridectomy for angle closure glaucoma: a two-year study. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975;79(3 Part 2):OP529-OP537.

3 Ritch R. Argon laser treatment for medically unresponsive attacks of angle-closure glaucoma. Am J Ophthalmol. 1982;94(2):197-204.

4 Lam DS, Leung DY, Tham CC, et al. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology. 2008;115(7):1134-1140.

5 Lee JW, Lee JH, Lee KW. Prognostic factors for the success of laser iridotomy for acute primary angle closure glaucoma. Korean J Ophthalmol. 2009;23(4):286-290.

6 Yeung BY, Ng PW, Chiu TY, et al. Prevalence and mechanism of appositional angle closure in acute primary angle closure after iridotomy. Clin Exp Ophthalmol. 2005;33(5):478-482.

7 Quigley HA. Long-term follow-up of laser iridotomy. Ophthalmology. 1981;88(3):218-224.

8 Elgin U, Berker N, Batman A, et al. Nd:YAG laser iridotomy in the management of secondary glaucoma associated with Behcet’s disease. Eur J Ophthalmol. 2007;17(2):191-195.

9 Ritch R, Solomon IS. Glaucoma surgery. In: L’Esperance FA, editor. Ophthalmic Lasers. 3rd edn. St. Louis: CV Mosby Co; 1988:650-748.

10 Ritch R, Palmberg P. Argon laser iridectomy in densely pigmented irides. Am J Ophthalmol. 1982;93(6):800-801.

11 Krupin T, Stone RA, Cohen BH, et al. Acute intraocular pressure response to argon laser iridotomy. Ophthalmology. 1985;92(7):922-926.

12 Goldberg MF, Tso MO, Mirolovich M. Histopathological characteristics of neodymium-YAG laser iridotomy in the human eye. Br J Ophthalmol. 1987;71(8):623-628.

13 Robin AL, Pollack IP. Q-switched neodymium-YAG laser iridotomy in patients in whom the argon laser fails. Arch Ophthalmol. 1986;104(4):531-535.

14 de Silva DJ, Gazzard G, Foster P. Laser iridotomy in dark irides. Br J Ophthalmol. 2007;91(2):222-225.

15 Murphy PH, Trope GE. Monocular blurring. A complication of YAG laser iridotomy. Ophthalmology. 1991;98(10):1539-1542.

16 Hong C, Kitazawa Y, Tanishima T. Influence of argon laser treatment of glaucoma on corneal endothelium. Jpn J Ophthalmol. 1983;27(4):567-574.

17 Panek WC, Lee DA, Christensen RE. The effects of Nd:YAG laser iridotomy on the corneal endothelium. Am J Ophthalmol. 1991;111(4):505-507.

18 Siam GA, de Barros DS, Gheith ME, et al. Post-peripheral iridotomy inflammation in patients with dark pigmentation. Ophthalmic Surg Lasers Imaging. 2008;39(1):49-53.

19 Landers J, Craig J. Decompression retinopathy and corneal oedema following Nd:YAG laser peripheral iridotomy. Clin Exp Ophthalmol. 2006;34(2):182-184.

20 Lim LS, Husain R, Gazzard G, et al. Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness. Ophthalmology. 2005;112(8):1355-1359.

21 Lai JS, Tham CC, Chua JK, et al. To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results. Eye. 2006;20(3):309-314.

22 Lam DS, Lai JS, Tham CC. Immediate argon laser peripheral iridoplasty as treatment for acute attack of primary angle-closure glaucoma: a preliminary study. Ophthalmology. 1998;105(12):2231-2236.

23 Lam DS, Lai JS, Tham CC, et al. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma: a prospective, randomized, controlled trial. Ophthalmology. 2002;109(9):1591-1596.

24 Tham CC, Lai JS, Lam DS. Immediate argon laser peripheral iridoplasty for acute attack of PACG (addendum to previous report). Ophthalmology. 1999;106(6):1042-1043.

25 Chew PT, Yeo LM. Argon laser iridoplasty in chronic angle closure glaucoma. Int Ophthalmol. 1995;19(2):67-70.

26 Ritch R, Tham CC, Lam DS. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology. 2004;111(1):104-108.

27 Tham CC, Lai JS, Poon AS, et al. Immediate argon laser peripheral iridoplasty (ALPI) as initial treatment for acute phacomorphic angle-closure (phacomorphic glaucoma) before cataract extraction: a preliminary study. Eye. 2005;19(7):778-783.

28 Yip PP, Leung WY, Hon CY, et al. Argon laser peripheral iridoplasty in the management of phacomorphic glaucoma. Ophthalmic Surg Lasers Imaging. 2005;36(4):286-291.

29 Ispa-Callen MC, Lara-Medina J, Zarco-Tejada JM, et al. [Argon laser iridoplasty as treatment of plateau-like iris configuration secondary to multiple ciliary body cysts: long-term follow-up by ultrasound biomicroscopy]. Arch Soc Esp Oftalmol. 2009;84(11):569-572.

30 Sbeity Z, Gvozdyuk N, Amde W, et al. Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure. J Glaucoma. 2009;18(4):269-271.

31 Mansouri K, Ravinet E. Argon-laser iridoplasty in the management of uveitis-induced acute angle-closure glaucoma. Eur J Ophthalmol. 2009;19(2):304-306.

Share this: